Company intelligence / Profile preview

Memidis Pharma

Nijmegen, Netherlands
Ownership
Private
Employees
~15
Development stage
Other
01

Overview

Memidis Pharma is a specialty pharmaceutical company based in the Netherlands that focuses exclusively on women's health, particularly in gynecology and urology. The company develops, licenses, and markets a diverse portfolio of products ranging from hormonal contraceptives and intrauterine devices to treatments for vaginal infections and menopausal symptoms. Notable products in their portfolio include the BeYaz contraceptive and the T-Safe copper IUD, alongside various non-hormonal options like the Caya diaphragm. Memidis emphasizes providing high-quality, evidence-based solutions that improve the quality of life for women across different life stages. They maintain a strong presence in the Benelux region while expanding their reach through strategic international partnerships.

Therapeutic areas
Women's Health
Modalities
Small moleculeHormoneDevice
Industry
Biotech
02

Drug pipeline

1 asset

MMPX1988

Preclinical
03

Partnerships

BayerMedinovaKessel med technology

Beyond the preview

Go deeper on Memidis Pharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Memidis Pharma.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call